CN1329519C - Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process - Google Patents
Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process Download PDFInfo
- Publication number
- CN1329519C CN1329519C CNB2006100658897A CN200610065889A CN1329519C CN 1329519 C CN1329519 C CN 1329519C CN B2006100658897 A CNB2006100658897 A CN B2006100658897A CN 200610065889 A CN200610065889 A CN 200610065889A CN 1329519 C CN1329519 C CN 1329519C
- Authority
- CN
- China
- Prior art keywords
- linolenic acid
- gamma
- selenium
- content
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 title claims abstract description 49
- 235000020664 gamma-linolenic acid Nutrition 0.000 title claims abstract description 49
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 229960002733 gamolenic acid Drugs 0.000 title claims abstract description 38
- 239000000843 powder Substances 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 14
- 230000008569 process Effects 0.000 title abstract description 5
- 230000000813 microbial effect Effects 0.000 title description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 29
- 239000011669 selenium Substances 0.000 claims abstract description 29
- 229940091258 selenium supplement Drugs 0.000 claims abstract description 29
- 238000000855 fermentation Methods 0.000 claims abstract description 16
- 230000004151 fermentation Effects 0.000 claims abstract description 16
- 230000001580 bacterial effect Effects 0.000 claims abstract description 15
- 238000000859 sublimation Methods 0.000 claims abstract description 13
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 11
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 11
- 239000011781 sodium selenite Substances 0.000 claims abstract description 11
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims description 27
- 229930006000 Sucrose Natural products 0.000 claims description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 12
- 239000005720 sucrose Substances 0.000 claims description 12
- 239000001888 Peptone Substances 0.000 claims description 9
- 108010080698 Peptones Proteins 0.000 claims description 9
- 235000019319 peptone Nutrition 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 241001290628 Cunninghamella echinulata Species 0.000 claims description 8
- 230000008022 sublimation Effects 0.000 claims description 8
- 238000011534 incubation Methods 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 6
- 235000013379 molasses Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 235000003276 Apios tuberosa Nutrition 0.000 claims 2
- 235000010744 Arachis villosulicarpa Nutrition 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 244000133018 Panax trifolius Species 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 2
- 235000012204 lemonade/lime carbonate Nutrition 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 229910052700 potassium Inorganic materials 0.000 claims 2
- 239000011591 potassium Substances 0.000 claims 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 1
- 240000002114 Satureja hortensis Species 0.000 claims 1
- 102000013275 Somatomedins Human genes 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 238000010899 nucleation Methods 0.000 claims 1
- 238000011218 seed culture Methods 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 33
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 5
- 229960004488 linolenic acid Drugs 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 150000003839 salts Chemical class 0.000 abstract description 3
- 230000003570 biosynthesizing effect Effects 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 231100000219 mutagenic Toxicity 0.000 abstract description 2
- 230000003505 mutagenic effect Effects 0.000 abstract description 2
- 241000024377 Cylindropuntia californica Species 0.000 abstract 1
- 239000003674 animal food additive Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 125000001477 organic nitrogen group Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 16
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 14
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 8
- 235000019341 magnesium sulphate Nutrition 0.000 description 8
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 8
- 235000019796 monopotassium phosphate Nutrition 0.000 description 8
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 description 7
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 235000017060 Arachis glabrata Nutrition 0.000 description 4
- 244000105624 Arachis hypogaea Species 0.000 description 4
- 235000018262 Arachis monticola Nutrition 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 235000020232 peanut Nutrition 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- -1 Compound amino acid Chemical class 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- SCWQRZHMKQEINE-UHFFFAOYSA-N selenous acid;sodium Chemical compound [Na].O[Se](O)=O SCWQRZHMKQEINE-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- ZUUFLXSNVWQOJW-MBIXAETLSA-N (2e,4e,6e)-octadeca-2,4,6-trienoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C(O)=O ZUUFLXSNVWQOJW-MBIXAETLSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012476 oxidizable substance Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及一种富含有机硒的γ-亚麻酸干菌粉及其生产工艺,以及生物合成该菌粉使用的诱变菌株。采用经诱变的刺孢小克银汉霉CGMCC NO.1652,在含有机碳源、有机氮源、无机盐、亚硒酸钠的培养基上进行富硒发酵,获得富含有机硒的γ-亚麻酸菌体,后采用微波真空冷冻升华干燥技术,获得油脂含量35-39%,γ-亚麻酸含量15-18%,硒含量139-330μg/g的γ-亚麻酸干菌粉。本发明经多次生产试验,技术成熟,工艺简单,绿色环保,适合于大规模工业化生产,具有原料来源广泛、成本低廉、质量好等特点。其产品,富含有机硒的γ-亚麻酸干菌粉,可广泛应用于医药、食品、饲料添加剂等领域。The invention relates to a dry bacterial powder of gamma-linolenic acid rich in organic selenium, a production process thereof, and a mutagenic strain used for biosynthesizing the bacterial powder. Using the mutagenized CGMCC No. 1652, silvery mildew C. californica was used to carry out selenium-enriched fermentation on a medium containing organic carbon sources, organic nitrogen sources, inorganic salts, and sodium selenite to obtain γ- The linolenic acid bacteria are then dried by microwave vacuum freeze-sublimation technology to obtain γ-linolenic acid dried bacteria powder with an oil content of 35-39%, a γ-linolenic acid content of 15-18%, and a selenium content of 139-330μg/g. After multiple production tests, the present invention has mature technology, simple process, environmental protection, is suitable for large-scale industrial production, and has the characteristics of wide source of raw materials, low cost, good quality and the like. Its product, γ-linolenic acid dried bacteria powder rich in organic selenium, can be widely used in medicine, food, feed additives and other fields.
Description
技术领域technical field
本发明涉及一种γ-亚麻酸干菌粉及其生产工艺,具体地说,涉及一种利用刺孢小克银汉霉的诱变菌株发酵生产富含有机硒的γ-亚麻酸干菌粉产品及其工艺。The present invention relates to a kind of gamma-linolenic acid dried bacteria powder and its production process, in particular to a kind of gamma-linolenic acid dried bacteria powder product rich in organic selenium fermented by the mutagenic strain of C. and its craft.
背景技术Background technique
γ-亚麻酸(Gamma-Linolenic Acid),简称GLA,分子式:C18H30O2,是一种十八碳三烯酸,属于多烯类活性物质。GLA为人体必需的不饱和脂肪酸,是一大类调节人体细胞自身活力的物质。它具有治疗高血压、高血脂、高血糖、糖尿病、纠正脂质代谢紊乱、治疗肝硬化和肾病综合症、抑制癌细胞繁殖、增强人体免疫功能的功效。Gamma-Linolenic Acid (Gamma-Linolenic Acid), GLA for short, molecular formula: C 18 H 30 O 2 , is a kind of octadecatrienoic acid, which belongs to polyene active substances. GLA is an essential unsaturated fatty acid for the human body, and it is a large class of substances that regulate the vitality of human cells. It has the effects of treating hypertension, hyperlipidemia, hyperglycemia, diabetes, correcting lipid metabolism disorders, treating liver cirrhosis and nephrotic syndrome, inhibiting the proliferation of cancer cells, and enhancing human immune function.
现有技术中一直是从月见草等植物中提取γ-亚麻酸,但由于原料的缺乏,导致γ-亚麻酸的产量受到限制,远远满足不了国内外市场的需求。近年来开发出一种生物合成γ-亚麻酸的方法,采用被孢霉、小克银汉霉等微生物菌种发酵生产γ-亚麻酸菌粉。生物合成的γ-亚麻酸主要成分,除含有多烯亚油酸(脉通的主要成分)和亚麻酸外,还含有抗突变、抗辐射、抗疲劳、抗衰老的超氧化物歧化酶(SOD),增强肌体免疫力的高分子多糖,以及蛋白质、多种氨基酸、维生素和微量元素。其多种有效成分的综合利用,经大量临床病理实验证明,疗效显著,无任何毒副作用,而且不含任何激素。In the prior art, gamma-linolenic acid has been extracted from plants such as evening primrose, but due to the lack of raw materials, the output of gamma-linolenic acid is limited, which is far from meeting the needs of domestic and foreign markets. In recent years, a method of biosynthesizing γ-linolenic acid has been developed, using Mortierella, C. chrysalis and other microbial strains to ferment and produce γ-linolenic acid powder. The main component of biosynthesized γ-linolenic acid, in addition to polyene linoleic acid (the main component of Maitong) and linolenic acid, also contains anti-mutation, anti-radiation, anti-fatigue, anti-aging superoxide dismutase (SOD ), high-molecular polysaccharides that enhance the body's immunity, as well as proteins, various amino acids, vitamins and trace elements. The comprehensive utilization of its multiple active ingredients has been proved by a large number of clinical and pathological experiments to have remarkable curative effect without any toxic and side effects, and does not contain any hormones.
硒元素,是人和动物生命活动不可缺少的微量元素。科学研究表明,四十多种疾病与硒元素有关,缺硒可引起贫血,心脑血管疾病,肝病,糖尿病,癌症,儿童发育不良,人体过早老化等。硒元素是多种抗氧化酶的活性中心,其抗氧化能力是Ve的400倍。它可有效抑制癌细胞的分裂和增殖,增强人体免疫力。硒的补充可净化血液、增强心肌动力。目前有人将亚麻酸纯品与硒元素采用化学方法合成硒化亚麻酸,得到了抗肿瘤效果明显的产品。但这种采用化学合成获得的产品中有化学溶酶残留,对人体有害,这个问题目前尚未解决。Selenium is an indispensable trace element for human and animal life activities. Scientific research shows that more than 40 kinds of diseases are related to selenium. Selenium deficiency can cause anemia, cardiovascular and cerebrovascular diseases, liver disease, diabetes, cancer, poor growth in children, and premature aging of the human body. Selenium is the active center of various antioxidant enzymes, and its antioxidant capacity is 400 times that of Ve. It can effectively inhibit the division and proliferation of cancer cells and enhance human immunity. Selenium supplementation can purify blood and enhance myocardial power. At present, some people use pure linolenic acid and selenium to synthesize selenized linolenic acid by chemical method, and obtain a product with obvious antitumor effect. However, there are chemical lysozyme residues in the product obtained by chemical synthesis, which is harmful to the human body, and this problem has not been solved yet.
发明内容Contents of the invention
本发明的目的之一是提供一种利用微生物发酵法(工业化)生产富含有机硒的γ-亚麻酸干菌粉的新工艺;目的之二是提供了一种没有任何化学溶酶残留的富含有机硒的γ-亚麻酸干菌粉产品;目的之三是提供了一株经诱变得到的高产GLA的耐硒菌株。One of purpose of the present invention is to provide a kind of novel technology that utilizes microbial fermentation method (industrialization) to produce the gamma-linolenic acid dry bacterial powder that is rich in organic selenium; γ-linolenic acid dry bacterial powder product containing organic selenium; the third purpose is to provide a selenium-resistant bacterial strain with high yield of GLA obtained through mutagenesis.
本发明采用下述技术方案来解决上述发明目的:The present invention adopts following technical scheme to solve above-mentioned invention object:
1.菌株诱变:本发明使用的刺孢小克银汉霉(Cunninghamella echinulata)CGMCC NO.1652,是以中国微生物菌种保藏委员会普通微生物中心提供的AS3.2473刺孢小克银汉霉为原始菌种,经诱变获得。具体诱变过程为:将幼龄菌丝进行处理获得原生质体,经过微波、亚硝基胍复合处理,将处理后的菌种悬液涂在合亚硒酸钠10mg/L-200mg/L的PDA平板上培养,挑出形态明显差异的菌株,后经过摇瓶复选而获得。该菌株与原始菌株相比具有生长速度快,孢子数量多,菌丝粗壮、传代后遗传性状稳定等特点。1. strain mutagenesis: Cunninghamella echinulata (Cunninghamella echinulata) CGMCC NO.1652 used in the present invention is based on the AS3.2473 Cunninghamella echinulata provided by the General Microbiology Center of China Microbiological Culture Collection Committee as the original bacteria species obtained by mutagenesis. The specific mutagenesis process is as follows: the young mycelium is processed to obtain protoplasts, and after microwave and nitrosoguanidine composite treatment, the treated strain suspension is coated with sodium selenite 10mg/L-200mg/L Cultivate on PDA plates, pick out the strains with obvious differences in morphology, and then obtain them through shake flask re-selection. Compared with the original strain, the strain has the characteristics of fast growth, large number of spores, strong hyphae, and stable genetic properties after subculture.
该菌株在PDA培养基上,温度28℃培养。2天菌落直径为2-5cm,菌丝为灰白色,有部分分生孢子形成;3-4天菌落直径为4-10cm,分生孢子大量形成,菌落为深灰色。The strain was cultured on PDA medium at a temperature of 28°C. On the 2nd day, the diameter of the colony was 2-5cm, the mycelium was off-white, and some conidia formed; on the 3rd-4th day, the diameter of the colony was 4-10cm, a large number of conidia formed, and the colony was dark gray.
菌丝初期无分隔,以后形成横隔。菌丝粗壮多分枝,直径约11-19微米。孢囊梗直立、分枝呈伞状。孢子囊单生,呈球形。分生孢子为球形或椭圆形,上有长刺,并且可以脱落。孢子直径9.5-13.2微米。分生孢子聚伞状,梅花状或不规则状。The hyphae have no septa at the beginning, and later form septa. The hyphae are thick and branched, about 11-19 microns in diameter. Cyst peduncle erect, branched umbrella-shaped. The sporangia are solitary and spherical. Conidia are spherical or oval, with long spines and can fall off. The spores are 9.5-13.2 microns in diameter. Conidia cymose, quincunx or irregular.
2.种液培养:将制成的孢子悬液接种于种子罐中进行培养。培养基的组成包括:蔗糖(或葡萄糖)3-5%,蛋白胨0.05-0.1%,磷酸二氢钾0.01-0.03%,硫酸镁0.01-0.03%,碳酸钙0.03-0.05%,亚硒酸钠0.0005-0.001%,PH5.5-6,温度22-30℃,培养时间24-36小时。2. Seed solution culture: inoculate the prepared spore suspension in the seed tank for cultivation. The composition of the medium includes: 3-5% of sucrose (or glucose), 0.05-0.1% of peptone, 0.01-0.03% of potassium dihydrogen phosphate, 0.01-0.03% of magnesium sulfate, 0.03-0.05% of calcium carbonate, and 0.0005% of sodium selenite -0.001%, pH 5.5-6, temperature 22-30°C, incubation time 24-36 hours.
3.发酵罐培养:将生长良好的种子液接入发酵罐中。发酵培养基的组成包括:蔗糖(或淀粉或糖蜜)8-15%,花生饼粉1-5%,蛋白胨1-5%,磷酸二氢钾0.01-0.03%,硫酸镁0.01-0.03%,碳酸钙0.03-0.05%,亚硒酸钠0.0005-0.001%,促生长因子微量,PH5.5-6,温度22-30℃,风量1:0.05-0.5v/v,搅拌速度150-200rpm,罐压0.02-0.08mpa,培养时间96-100小时。3. Fermentation tank culture: put the well-grown seed liquid into the fermentation tank. The composition of the fermentation medium includes: 8-15% of sucrose (or starch or molasses), 1-5% of peanut powder, 1-5% of peptone, 0.01-0.03% of potassium dihydrogen phosphate, 0.01-0.03% of magnesium sulfate, carbonic acid Calcium 0.03-0.05%, sodium selenite 0.0005-0.001%, trace growth factor, PH5.5-6, temperature 22-30℃, air volume 1: 0.05-0.5v/v, stirring speed 150-200rpm, tank pressure 0.02-0.08mpa, culture time 96-100 hours.
4.菌体收集:将得到的γ-亚麻酸鲜菌体采用微波真空冷冻升华干燥法进行干燥。反应参数如下:4. Thalline collection: the obtained fresh gamma-linolenic acid bacteria are dried by microwave vacuum freeze-sublimation drying method. The reaction parameters are as follows:
真空室:直径1.6m,长13m,真空度30mbarVacuum chamber: diameter 1.6m, length 13m, vacuum degree 30mbar
输入微波频率:2450MHz±50MHzInput microwave frequency: 2450MHz±50MHz
输入微波功率:48KW±2KWInput microwave power: 48KW±2KW
使用玻璃增强聚四氟乙烯传输带进行传送。Conveyors are carried out using glass reinforced PTFE conveyor belts.
将在-5℃下预冻结的γ-亚麻酸鲜菌体放在传送带上,80-100T的低压下输入微波能量,加热40分钟,并保持温度15-20%的热风对流,由里向外蒸发水份。干燥时间共4-6小时。Put the γ-linolenic acid fresh bacteria pre-frozen at -5°C on the conveyor belt, input microwave energy at a low pressure of 80-100T, heat for 40 minutes, and keep the temperature at 15-20% of the hot air convection, from the inside to the outside Evaporate water. The drying time is 4-6 hours in total.
本发明的产品技术指标如下:每100g干菌粉中,Product technical index of the present invention is as follows: in every 100g dried bacteria powder,
油脂含量:35-39%Oil content: 35-39%
γ-亚麻酸含量:15-18%Gamma-linolenic acid content: 15-18%
硒含量:139-330μg/gSelenium content: 139-330μg/g
复合氨基酸:3.5-6.8gCompound amino acid: 3.5-6.8g
蛋白多糖:4-7gProteoglycan: 4-7g
超氧化物歧化酶(SOD):543.7μg/gSuperoxide dismutase (SOD): 543.7μg/g
采用上述的技术方案实施本发明,其主要的有益效果如下:Adopt above-mentioned technical scheme to implement the present invention, its main beneficial effect is as follows:
1.使用诱变的菌株发酵生产γ-亚麻酸,在筛选高产GLA菌株的同时,用含有高浓度硒的培养基对菌株进行培养,筛选出含硒的耐硒菌株(普通的刺孢小克银汉霉不能耐硒生长),并在发酵培养中采取了相应的条件,获得了既含GLA又富含有机硒的γ-亚麻酸干菌粉产品,其中γ-亚麻酸的含量在12-15%,最高可达18%。同时,含有丰富的硒,硒含量高达139-330μg/g。实验证明,多种具有生理功能物质的协同作用可明显提高产品的功效。1. Use the mutagenized bacterial strain to ferment and produce γ-linolenic acid. While screening high-yield GLA strains, culture the bacterial strain with a medium containing high-concentration selenium, and screen out selenium-containing selenium-resistant bacterial strains (common C. Yinhan mold can not tolerate selenium growth), and adopted corresponding conditions in the fermentation culture, obtained the gamma-linolenic acid dry bacterial powder product that not only contains GLA but also is rich in organic selenium, wherein the content of gamma-linolenic acid is 12-15 %, up to 18%. At the same time, it is rich in selenium, and the selenium content is as high as 139-330μg/g. Experiments have proved that the synergistic effect of various substances with physiological functions can significantly improve the efficacy of the product.
2.制备过程中,主要原料(碳源、氮源)全部采用天然有机物,不使用无机原料,提高了产品的安全程度,绿色环保。2. During the preparation process, the main raw materials (carbon source and nitrogen source) are all natural organic matter, and no inorganic raw materials are used, which improves the safety of the product and is environmentally friendly.
3.针对产品油脂含量高、易氧化等特点,采用微波真空冷冻升华干燥法对产品进行干燥。该法是将真空微波干燥和真空冷冻升华干燥有机结合到一起,微波在此处主要起到加热的作用。过去在真空冷冻升华技术中,加热采用电加热或热泵机组等装置,采用微波后,可以取消上述装置。冷冻干燥的基本原理,是基于水的三态变化,三种相态既可以相互转换又可以共存。当水在三相点(温度0.01℃,水蒸气压610.5Pa)时,水、冰、水蒸气三者可共存且相互平衡。在高真空状态下,利用升华原理,使预先冻结的γ-亚麻酸菌体中的水份不经过冰的溶化, 直接以冰态升华为水蒸气被除去,从而达到冷冻干燥的目的。冻干的γ-亚麻酸菌体成海绵状、无干缩、复水性极好、含水分极少,相应包装后可在常温下长时间保存和运输。相对于其它干燥方法,微波真空冷冻升华干燥法的优点如下:3. In view of the characteristics of high oil content and easy oxidation of the product, the product is dried by microwave vacuum freeze-sublimation drying method. This method is an organic combination of vacuum microwave drying and vacuum freeze-sublimation drying, where microwaves mainly play the role of heating. In the past, in the vacuum freezing and sublimation technology, devices such as electric heating or heat pump units were used for heating. After using microwaves, the above devices can be eliminated. The basic principle of freeze-drying is based on the three-state change of water, and the three phases can be converted to each other and can coexist. When water is at the triple point (temperature 0.01°C, water vapor pressure 610.5Pa), water, ice, and water vapor can coexist and balance each other. In a high vacuum state, using the principle of sublimation, the water in the pre-frozen γ-linolenic acid bacteria can be directly sublimated into water vapor in the ice state and removed without melting the ice, so as to achieve the purpose of freeze-drying. Freeze-dried γ-linolenic acid bacteria form a spongy shape, no drying shrinkage, excellent rehydration, and very little water content. After corresponding packaging, it can be stored and transported at room temperature for a long time. Compared with other drying methods, the advantages of microwave vacuum freeze sublimation drying are as follows:
许多热敏性物质不会发生变性或失活;Many heat-sensitive substances will not be denatured or inactivated;
在低温下干燥时,γ-亚麻酸菌体中的一些挥发性成分损失很小;When drying at low temperature, some volatile components in the gamma-linolenic acid bacteria lose very little;
低温下,微生物的生长和酶的作用无法进行,因此产品能保持原来的状态;At low temperature, the growth of microorganisms and the action of enzymes cannot be carried out, so the product can maintain its original state;
由于在冻结状态下进行干燥,因此产品体积几乎不变,保持了γ-亚麻酸菌体原来的结构,不会发生浓缩现象;Due to drying in a frozen state, the volume of the product is almost unchanged, and the original structure of the gamma-linolenic acid bacteria is maintained, and no concentration phenomenon occurs;
由于γ-亚麻酸菌体中的水分在预冻以后以冰晶的形态存在,原来溶于水中的无机盐类物质被均匀的分配在γ-亚麻酸的菌体中。升华时,溶于水中的溶解物质就析出,避免了一般干燥方法中γ-亚麻酸菌体内部水分向表面迁移所携带的无机盐在表面析出而造成表面硬化的现象;Since the water in the gamma-linolenic acid cells exists in the form of ice crystals after pre-freezing, the inorganic salts originally dissolved in water are evenly distributed in the gamma-linolenic acid cells. During sublimation, the dissolved substances in water are precipitated, which avoids the phenomenon of surface hardening caused by the precipitation of inorganic salts carried by the internal moisture of γ-linolenic acid cells to the surface in the general drying method;
干燥后的γ-亚麻酸菌体疏松多孔,呈海绵状,加水后溶解迅速而完全,几乎立即恢复原来的状态;The dried gamma-linolenic acid bacteria are loose and porous, in the shape of a sponge, and dissolve quickly and completely after adding water, and almost immediately return to the original state;
由于干燥在真空下进行,氧气极少,因此一些易氧化物质得到了保护;Since the drying is carried out under vacuum, there is very little oxygen, so some easily oxidizable substances are protected;
干燥能排除95-99%以上的水分,使干燥后的γ-亚麻酸菌体能长期保存而不致变质。Drying can remove more than 95-99% of water, so that the dried gamma-linolenic acid bacteria can be stored for a long time without deterioration.
由于上述优点的存在,采用该方法进行干燥可提高γ-亚麻酸干菌粉的各项技术指标1-3个百分点,有效提高γ-亚麻酸干菌粉的附加值。Due to the existence of the above-mentioned advantages, the method of drying can increase the technical indicators of the gamma-linolenic acid dried bacteria powder by 1-3 percentage points, and effectively increase the added value of the gamma-linolenic acid dried bacteria powder.
4.采用生物发酵法获得的富含有机硒的γ-亚麻酸干菌粉与化学合成的硒化亚麻酸相比,没有任何化学溶酶残留,对人体无任何毒副作用,并且多种具有生理功能物质的协同作用可明显提高产品的功效。4. Compared with chemically synthesized selenized linolenic acid, γ-linolenic acid dried bacteria powder rich in organic selenium obtained by biological fermentation method has no chemical lysozyme residue, no toxic and side effects on the human body, and a variety of physiological The synergistic effect of functional substances can obviously improve the efficacy of the product.
5.生产发酵全过程,设立无菌区并采用全封闭作业,计算机全程监控,能保证γ-亚麻酸干菌粉的质量,降低工业化生产成本。5. In the whole process of production and fermentation, a sterile area is set up and a fully enclosed operation is adopted, and the computer monitors the whole process, which can ensure the quality of the dried γ-linolenic acid powder and reduce the cost of industrial production.
本发明使用的刺孢小克银汉霉(Cunninghamellaechinulata)已经于2006年3月16日保藏于中国微生物菌种保藏委员会普通微生物中心,保藏号为CGMCC NO.1652。Cunninghamellaechinulata used in the present invention has been preserved in the General Microorganism Center of China Committee for the Collection of Microorganisms on March 16, 2006, and the preservation number is CGMCC NO.1652.
具体实施方式Detailed ways
下列实施例将进一步说明本发明。The following examples further illustrate the invention.
实施例1:1吨发酵罐生产菌体Embodiment 1: 1 ton fermenter produces thalline
1.将斜面菌种CGMCC NO.1652接种于克氏瓶中扩大培养,温度22-30℃,培养3-5天。1. Inoculate the slant strain CGMCC NO.1652 into a Kirschner flask for expanded cultivation at a temperature of 22-30°C for 3-5 days.
2.将菌种制成菌悬液接种于种子罐中,种子罐容积为100升,培养基:蔗糖4kg,蛋白胨0.4kg,磷酸二氢钾20g,硫酸镁20g,碳酸钙35g,亚硒酸钠2.1g,PH5.5-6,温度25-30℃,风量1∶0.5v/v,搅拌速度150-200rpm,培养时间为32小时。2. Inoculate the bacteria suspension into the seed tank, the volume of the seed tank is 100 liters, medium: 4 kg of sucrose, 0.4 kg of peptone, 20 g of potassium dihydrogen phosphate, 20 g of magnesium sulfate, 35 g of calcium carbonate, selenous acid Sodium 2.1g, pH 5.5-6, temperature 25-30°C, air volume 1:0.5v/v, stirring speed 150-200rpm, incubation time 32 hours.
3.将种子液转接到发酵罐中,发酵罐容积1000升。培养基:蔗糖72kg,花生饼粉4kg,磷酸二氢钾200g,硫酸镁200g,碳酸钙350g,亚硒酸钠21g,促生长因子2.3g,PH5.5-6,温度22-30℃,风量1∶0.25-0.55v/V,搅拌速度150-200rpm,罐压0.02-0.08mpa,培养96小时。3. Transfer the seed liquid to a fermenter with a volume of 1000 liters. Medium: 72kg sucrose, 4kg peanut cake powder, 200g potassium dihydrogen phosphate, 200g magnesium sulfate, 350g calcium carbonate, 21g sodium selenite, 2.3g growth-promoting factor, PH5.5-6, temperature 22-30℃, air volume 1: 0.25-0.55v/V, stirring speed 150-200rpm, tank pressure 0.02-0.08mpa, culture for 96 hours.
4.菌体收集,采用微波真空冷冻升华技术,输入微波频率2400MHz,输入微波功率46KW,加热40分钟,并保持温度15-20%的热风对流,干燥4-6小时。得菌体31.5kg,其中每100g干菌粉中油脂含量35.5%,GLA含量12.5%,硒含量139.2μg/g。4. Bacterial cells are collected using microwave vacuum freeze-sublimation technology, input microwave frequency 2400MHz, input microwave power 46KW, heat for 40 minutes, and maintain the temperature of 15-20% hot air convection, and dry for 4-6 hours. 31.5 kg of bacteria were obtained, wherein the oil content per 100 g of dry bacteria powder was 35.5%, the GLA content was 12.5%, and the selenium content was 139.2 μg/g.
实施例2:5吨发酵罐生产菌体Embodiment 2: 5 tons of fermentation tanks produce thalline
1.将斜面菌种CGMCC NO.1652接种于克氏瓶中扩大培养,温度22-30℃,培养3天。1. Inoculate the slant strain CGMCC NO.1652 into a Kirschner flask for expanded cultivation at a temperature of 22-30°C for 3 days.
2.将菌种制成菌悬液接种于种子罐中,种子罐容积为500升,培养基:蔗糖15kg,蛋白胨3.5kg,磷酸二氢钾90g,硫酸镁90g,碳酸钙150g,亚硒酸钠12g,PH5.5-6,温度22-30℃,风量1∶0.3v/v,搅拌速度150-200rpm,罐压0.02-0.08mpa,培养时间为28小时。2. Inoculate the bacteria suspension into the seed tank, the volume of the seed tank is 500 liters, the medium: sucrose 15kg, peptone 3.5kg, potassium dihydrogen phosphate 90g, magnesium sulfate 90g, calcium carbonate 150g, selenous acid Sodium 12g, pH 5.5-6, temperature 22-30°C, air volume 1:0.3v/v, stirring speed 150-200rpm, tank pressure 0.02-0.08mpa, incubation time 28 hours.
3.将种子液转接到发酵罐中,发酵罐容积5000升。培养基:蔗糖400kg,花生饼粉35kg,磷酸二氢钾900g,硫酸镁900g,碳酸钙1500g,亚硒酸钠120g,促生长因子10.5g,PH5.5-6,温度22-30℃,发酵至糖含量4%时,补加100kg灭菌后的糖蜜,风量1∶0.1-0.3v/v,搅拌速度150-200rpm,罐压0.02-0.08mpa,培养100小时。3. Transfer the seed solution to a fermenter with a capacity of 5000 liters. Medium: 400kg sucrose, 35kg peanut cake powder, 900g potassium dihydrogen phosphate, 900g magnesium sulfate, 1500g calcium carbonate, 120g sodium selenite, 10.5g growth-promoting factor, PH5.5-6, temperature 22-30℃, fermentation When the sugar content is 4%, add 100kg of sterilized molasses, air volume 1: 0.1-0.3v/v, stirring speed 150-200rpm, tank pressure 0.02-0.08mpa, and cultivate for 100 hours.
4.菌体收集,同实施例1。得菌体128kg,其中每100g干菌粉中,油脂含量32.3%,GLA含量18.1%,硒含量142.4μg/g。4. Bacteria collection, with embodiment 1. 128 kg of bacteria were obtained, wherein in every 100 g of dry bacteria powder, the oil content was 32.3%, the GLA content was 18.1%, and the selenium content was 142.4 μg/g.
实施例3:5吨发酵罐生产菌体Embodiment 3: 5 tons of fermentation tanks produce thalline
1.将斜面菌种CGMCC NO.1652接种于克氏瓶中扩大培养,温度22-30℃,培养3-4天。1. Inoculate the slant strain CGMCC NO.1652 into a Kirschner flask for expanded cultivation at a temperature of 22-30°C for 3-4 days.
2.将菌种制成菌悬液接种于种子罐中,种子罐容积为500升,培养基:蔗糖15kg,蛋白胨3.5kg,磷酸二氢钾90g,硫酸镁90g,碳酸钙150g,亚硒酸钠12g,PH5.5-6,温度25-30℃,风量1∶0.3v/v,搅拌速度150-200rpm,罐压0.02-0.08mpa,培养时间为30小时。2. Inoculate the bacteria suspension into the seed tank, the volume of the seed tank is 500 liters, the medium: sucrose 15kg, peptone 3.5kg, potassium dihydrogen phosphate 90g, magnesium sulfate 90g, calcium carbonate 150g, selenous acid Sodium 12g, pH 5.5-6, temperature 25-30°C, air volume 1:0.3v/v, stirring speed 150-200rpm, tank pressure 0.02-0.08mpa, incubation time 30 hours.
3.将种子液转接到发酵罐中,发酵罐容积5000升。培养基:蔗糖400kg,花生饼粉35kg,磷酸二氢钾900g,硫酸镁900g,碳酸钙1500g,亚硒酸钠120g,促生长因子10.5g,PH5.5-6,温度25-30℃,发酵至糖含量10%时,补加80kg灭菌后的糖蜜,风量1∶0.1-0.3v/v,搅拌速度150-200rpm,罐压0.02-0.08mpa,培养100小时。3. Transfer the seed solution to a fermenter with a volume of 5000 liters. Medium: sucrose 400kg, peanut cake powder 35kg, potassium dihydrogen phosphate 900g, magnesium sulfate 900g, calcium carbonate 1500g, sodium selenite 120g, growth-promoting factor 10.5g, pH5.5-6, temperature 25-30℃, fermentation When the sugar content is 10%, add 80kg of sterilized molasses, air volume 1: 0.1-0.3v/v, stirring speed 150-200rpm, tank pressure 0.02-0.08mpa, and cultivate for 100 hours.
4.菌体收集,同实施例1。得菌体120kg,其中每100g干菌粉中油脂含量37.3%,GLA含量16.2%,硒含量168.5μg/g。4. Bacteria collection, with embodiment 1. 120 kg of thalline was obtained, wherein the oil content per 100 g of dry bacterial powder was 37.3%, the GLA content was 16.2%, and the selenium content was 168.5 μg/g.
实施例4:5吨发酵罐生产菌体Embodiment 4: 5 tons of fermentation tanks produce thalline
1.将斜面菌种CGMCC NO.1652接种于克氏瓶中扩大培养,温度22-30℃,培养3-4天。1. Inoculate the slant strain CGMCC NO.1652 into a Kirschner flask for expanded cultivation at a temperature of 22-30°C for 3-4 days.
2.将菌种制成菌悬液接种于种子罐中,其中温度22℃,罐压0.05mpa,其余同实施例3。2. Inoculate the bacteria suspension into the seed tank with the temperature of 22° C. and the pressure of the tank at 0.05 mpa, and the rest are the same as in Example 3.
3.将种子液转接到发酵罐中,其中温度30℃,罐压0.08mpa,搅拌速度180rpm,其余同实施例3。3. Transfer the seed solution to a fermenter, where the temperature is 30°C, the tank pressure is 0.08mpa, and the stirring speed is 180rpm, and the rest are the same as in Example 3.
4.菌体收集,同实施例1。得菌体118kg,其中每100g干菌粉中油脂含量35.2%,GLA含量17.0%,硒含量156.3μg/g。4. Bacteria collection, with embodiment 1. 118 kg of thalline was obtained, wherein the oil content per 100 g of dry bacterial powder was 35.2%, the GLA content was 17.0%, and the selenium content was 156.3 μg/g.
对比实施例1:1吨发酵罐生产菌体Comparative example 1: 1 ton fermenter produces thalline
1.同实施例1。2.同实施例1。3.同实施例1。1. Same as Example 1. 2. Same as Example 1. 3. Same as Example 1.
4.菌体收集,采用硫化床干燥法。干燥时间6-8小时,温度50-70℃。4. Bacteria were collected by using the fluidized bed drying method. The drying time is 6-8 hours, and the temperature is 50-70°C.
结果比较Result comparison
对比实施例2:5吨发酵罐生产菌体Comparative example 2: 5 tons of fermentation tanks produce thalline
1.同实施例3。1. Same as embodiment 3.
2.同实施例3。2. Same as embodiment 3.
3.同实施例3。3. Same as embodiment 3.
4.菌体收集,采用硫化床干燥法。干燥时间6-8小时,温度50-70℃。4. Bacteria were collected by using the fluidized bed drying method. The drying time is 6-8 hours, and the temperature is 50-70°C.
结果比较Result comparison
值得说明的是,本发明可用其它的不违背本发明的精神或主要特征的具体形式来概述。因此,无论从哪一点来看,本发明的上述实施方案都只能认为是对本发明的说明而不能限制本发明。It should be noted that the present invention can be summarized in other specific forms without departing from the spirit or main characteristics of the present invention. Therefore, no matter from which point of view, the above-mentioned embodiments of the present invention can only be considered as illustrations of the present invention rather than limiting the present invention.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100658897A CN1329519C (en) | 2006-03-29 | 2006-03-29 | Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100658897A CN1329519C (en) | 2006-03-29 | 2006-03-29 | Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1858216A CN1858216A (en) | 2006-11-08 |
| CN1329519C true CN1329519C (en) | 2007-08-01 |
Family
ID=37297174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100658897A Expired - Fee Related CN1329519C (en) | 2006-03-29 | 2006-03-29 | Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1329519C (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4564634A (en) * | 1982-05-28 | 1986-01-14 | F.C.N.S.R.L. | Selenium compounds having antineoplastic activity, process for the preparation thereof and pharmaceutical compositions therefrom |
| CN1069070A (en) * | 1991-07-30 | 1993-02-17 | 中国科学院沈阳应用生态研究所 | Method for preparing gamma-linolenic acid and biological preparation mainly containing gamma-linolenic acid |
| CN1255540A (en) * | 1999-11-12 | 2000-06-07 | 沈阳大有生物工程有限责任公司 | Process for preparing biologic preparation containing linolenic acid |
-
2006
- 2006-03-29 CN CNB2006100658897A patent/CN1329519C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4564634A (en) * | 1982-05-28 | 1986-01-14 | F.C.N.S.R.L. | Selenium compounds having antineoplastic activity, process for the preparation thereof and pharmaceutical compositions therefrom |
| CN1069070A (en) * | 1991-07-30 | 1993-02-17 | 中国科学院沈阳应用生态研究所 | Method for preparing gamma-linolenic acid and biological preparation mainly containing gamma-linolenic acid |
| CN1255540A (en) * | 1999-11-12 | 2000-06-07 | 沈阳大有生物工程有限责任公司 | Process for preparing biologic preparation containing linolenic acid |
Non-Patent Citations (1)
| Title |
|---|
| 硒化亚麻酸的抗癌作用研究 薛少安 等,营养学报,第14卷第4期 1992 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1858216A (en) | 2006-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105586279B (en) | A kind of Trichoderma spp. direct fermentation crop material prepares the method for Trichoderma spp. solid spawn and the product of preparation | |
| CN104086305B (en) | A kind of Cordyccps-militaris-(L.)-link. Sporophore substratum | |
| CN102067885A (en) | Trichoderma spore powder as well as preparation method and application thereof | |
| CN101497901B (en) | Novel technological process for producing high optical purity L-lactic acid by semi-continuous high-density fermentation of Rhizopus oryzae | |
| CN116355814B (en) | A strain of Escherichia coli and its application in fermentative production of L-arginine | |
| CN108796026A (en) | Production, extraction and the purifying process of lysine | |
| CN108676830A (en) | The method of lactobacillus plantarum ZJ316 high density fermentation bacteriocinogeny | |
| CN102559552A (en) | Production method and application of high-yield gamma-aminobutyric acid | |
| CN103932198A (en) | Preparation method for selenium-enriched glutathione beer yeast biological product by utilizing waste beer yeast | |
| CN110229852A (en) | A method of utilizing soybean protein hydrolysate fermenting and producing gamma-polyglutamic acid | |
| CN115181707A (en) | A strain of Bacillus subtilis and its liquid-solid two-phase fermentation method | |
| CN108796004A (en) | A kind of technique of preparing lysine through fermentation | |
| CN108719991B (en) | A method for preparing red yeast rice containing natto bacteria by utilizing bean dregs and tofu yellow slurry water | |
| CN106867937A (en) | With the bacterial strain of pea protein wastewater liquid fermenting and producing Bacillus subtilis natto microbial inoculum, method and application | |
| Khan et al. | Effect of various agriculture wastes and pure sugars on the production of single cell protein by Penicillium expansum | |
| CN110859240A (en) | A kind of dry-wet mixed full-price feed and preparation method thereof | |
| CN103070378B (en) | Method for preparing pickled cucumbers by fermenting with mixed cultures | |
| CN102676408B (en) | The method of ocean rhodotorula is produced in a kind of high density liquid submerged fermentation | |
| CN115895904A (en) | Mucor indicum, screening method and application thereof | |
| CN1329519C (en) | Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process | |
| CN105524863B (en) | A method for high-density production of Bacillus amyloliquefaciens by combining liquid and semi-solid fermentation processes | |
| CN113046253A (en) | Culture method for improving heat resistance of kluyveromyces marxianus | |
| CN103773698B (en) | A kind of preparation method of high-effective microorganism fertilizer | |
| CN103773717B (en) | A kind of high-effective microorganism is fertile | |
| CN115960767B (en) | Lactobacillus plantarum and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070801 Termination date: 20180329 |